Verona raises $80M, lists on NASDAQ

Respiratory disease company Verona Pharma plc (LSE:VRP; NASDAQ:VRNA) traded flat on NASDAQ Thursday, ending the day at $13.50, after it raised $80 million in a NASDAQ listing and concurrent private placement, both underwritten by Jefferies, Stifel, PacGrow and SunTrust Robinson Humphrey.

In the listing, Verona sold 5.8 million ADSs at $13.50. Each ADS is worth eight ordinary shares. In the private placement, it sold 1.3 million ordinary shares at £1.32 to investors outside the U.S. and Canada...